Encapsulated interleukin 10 vaccine - TherapyX
Alternative Names: GneXa10TMLatest Information Update: 28 Dec 2023
At a glance
- Originator TherapyX
- Class Anti-inflammatories; Bacterial vaccines; Interleukins
- Mechanism of Action Immunomodulators; Interleukin 10 replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Genital tract infections; Gonorrhoea
Most Recent Events
- 28 Dec 2023 No recent reports of development identified for preclinical development in Genital-tract-infections in USA (Vaginal)
- 28 Dec 2023 No recent reports of development identified for preclinical development in Gonorrhoea in USA (Vaginal)
- 04 Dec 2019 Encapsulated interleukin 10 vaccine - TherapyX is available for licensing as of 04 Dec 2019. http://therapyxinc.com/investor-information/